Introduction: Medical congresses allow scientific production to be appropriately disseminated and discussed. However, most of the scientific papers presented at medical congresses do not go on to be published in indexed journals. The present study aimed to characterize the abstracts presented at three different congresses on breast cancer held in Brazil, and to determine the publication rate of these three events. Methods: Observational, retrospective study, where the observation unit consisted of the scientific papers presented at the Brazilian Congress of Mastology (CBM), Jornada Paulista de Mastologia (JPM) and Brazilian Breast Cancer Symposium (BBCS) in 2017. Initially, we recorded all the abstracts of works presented at the event. Subsequently, the works were searched in digital databases (BIREME/LILACS and MEDLINE/PubMed) and in the respective resumes of the authors on the Lattes platform. Results: The study included 266 abstracts of scientific papers presented in the three selected events, of which 21 (7.9%) were published in an indexed journal. Most of these studies were conducted predominantly in public institutions (71.1%), located in the State of São Paulo (30.5%) and were presented in the form of a poster (77.8%). The publication rate from the BBCS, CBM and JPM was 13.4, 5.4 and 3.4%, respectively (p = 0.03). Considering the published articles, there was no difference in journal impact factor between the congresses (p = 0.49). “Mastology” was the journal that received the largest number of publications (n = 8; 38.1%). Conclusion: In 2017, less than 10% of the abstracts on breast cancer presented at Brazilian congresses were published in an indexed journal. Among the main specialty events in the country, the Brazilian Breast Cancer Symposium has a significantly higher publication rate.
Medical congresses allow scientific production to be appropriately disseminated and discussed. However, most of the scientific papers presented at medical congresses do not go on to be published in indexed journals. The present study aimed to determine the publication rate of papers presented at the Brazilian Breast Cancer Symposium (BBCS) and trends associated with publication over that timeframe.Methods: This was a retrospective, observational study evaluating scientific papers presented at the BBCS between 2012 and 2017. All the abstracts presented at the event within this timeframe were recorded. Next, a search for papers was made using online databases (BIREME/LILACS and MEDLINE/PubMed) and in the curricula of the authors on the Lattes Platform.Results: Overall, 543 abstracts of papers presented at the BBCS between 2012 and 2017 were included. Of these, 112 (20.6%) had been published in an indexed journal, mostly in English (67.0%), in journals with an impact factor of 2.0-3.0 (21.4%) and ≥1 year after presentation at the event (75.9%). The factors associated with publication were: study conducted in a public institution (p = 0.01), oral or commented poster presentation (p > 0.001) and study concerning rehabilitation following breast cancer (p = 0.04). There was a downward trend in the rate of publication of articles over the years (p = 0.01). Conversely, the impact factor of the publications increased significantly between 2012 and 2017 (p = 0.04). Conclusion:The publication rate of papers presented at the BBCS is low and remains consistent over the study period despite academic incentives and substantial awards.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.